Literature DB >> 22526196

Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty.

Torsten Kluba1, Katrin Fiedler, Beate Kunze, Ingmar Ipach, Andreas Suckel.   

Abstract

BACKGROUND: Total knee arthroplasty is associated with a significant postoperative blood loss even without any form of perioperative anticoagulation.
METHODS: The potential role of QUIXIL(®), a fibrin sealant used in orthopaedic surgery to control blood loss and avoid blood transfusions in patients undergoing total knee arthroplasty was evaluated in a prospective randomized trial with twenty-four patients diagnosed with primary osteoarthritis of the knee.
RESULTS: Results showed that application of 2 ml QUIXIL(®) adds costs to treatment without reducing the number of transfused red blood cell counts and postoperative haemoglobin loss. However, significant lower levels of postoperative fluid loss (P = 0.026) was detected in QUIXIL(®) treated patients.
CONCLUSION: Regarding cost effectiveness and benefit no indication for the use of 2 ml QUIXIL(®) fibrin sealant in standard knee arthroplasty could be proofed statistically.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526196     DOI: 10.1007/s00402-012-1519-2

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  8 in total

1.  Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis.

Authors:  Marco Scardino; Federica Martorelli; Tiziana D'Amato; Giorgia Fenocchio; Vincenzo Simili; Guido Grappiolo; Berardo Di Matteo; Elizaveta Kon; Michele Lagioia
Journal:  Int Orthop       Date:  2019-01-23       Impact factor: 3.075

2.  Fibrin sealant before wound closure in total knee arthroplasty reduced blood loss: a meta-analysis.

Authors:  Zhi-Jun Li; Xin Fu; Peng Tian; Wen-Xing Liu; Yao-Min Li; Yong-Fa Zheng; Xin-Long Ma; Wei-Min Deng
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-12       Impact factor: 4.342

3.  Does a thrombin-based topical haemostatic agent reduce blood loss and transfusion requirements after total knee revision surgery? A randomized, controlled trial.

Authors:  Carlo L Romanò; Lorenzo Monti; Nicola Logoluso; Delia Romanò; Lorenzo Drago
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-07-11       Impact factor: 4.342

4.  Determination of the efficacy of EVICEL™ on blood loss in orthopaedic surgery after total knee replacement: study protocol for a randomised controlled trial.

Authors:  S Budde; Y Noll; V Zieglschmid; C Schroeder; A Koch; H Windhagen
Journal:  Trials       Date:  2015-07-11       Impact factor: 2.279

5.  A prospective, randomized, comparative study of intravenous alone and combined intravenous and intraarticular administration of tranexamic acid in primary total knee replacement.

Authors:  Paolo Adravanti; Eleonora Di Salvo; Giuseppe Calafiore; Sebastiano Vasta; Aldo Ampollini; Michele Attilio Rosa
Journal:  Arthroplast Today       Date:  2017-10-06

Review 6.  Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective.

Authors:  William D Spotnitz
Journal:  ISRN Surg       Date:  2014-03-04

Review 7.  Is fibrin sealant effective and safe in total knee arthroplasty? A meta-analysis of randomized trials.

Authors:  Hongsheng Wang; Liancheng Shan; Hui Zeng; Mengxiong Sun; Yingqi Hua; Zhengdong Cai
Journal:  J Orthop Surg Res       Date:  2014-05-16       Impact factor: 2.359

8.  The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial.

Authors:  Wiebe C Verra; Joost A van Hilten; Áine Honohan; Erik W van Zwet; Johanna G van der Bom; Rob G H H Nelissen
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.